Filler for feminine rejuvenation: new study tests hyaluronic acid injections
NCT ID NCT07402395
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a hyaluronic acid filler (BtH Intimate 2.0%) injected into the labia and pubic area of 40 women with mild to moderate vulvar atrophy. The goal was to restore volume, improve appearance, and ease symptoms. Participants were followed for 6 months after a single treatment, with an optional touch-up at 4 weeks. The study measured aesthetic improvement, safety, patient satisfaction, and sexual function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cross-linked hyaluronic acid (BtH Intimate 2.0%)
What this could lead to
If it works, this could offer a non-surgical option to improve comfort, appearance, and quality of life for women with vulvar atrophy.
What could go wrong
This is a small, single-center study with no control group. Results may not apply to all women, and long-term effects beyond 6 months are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVAR ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Complutense Medical Center (Virtus Group)
Madrid, Madrid, 28805, Spain